<?xml version="1.0" encoding="utf-8"?><?xml-stylesheet type="text/xsl" href="/prwebFeeds.xsl"?><rss version="2.0"><channel><title>PRWeb.com Press Release Feed - PRWeb Press Release Account Feed</title><link>http://www.prweb.com</link><description>PRWeb.com Press Release Feed - Press Releases</description><language>en</language><managingEditor>xml@emediawire.com</managingEditor><webMaster>xml@emediawire.com</webMaster><lastBuildDate>Fri, 15 Jul 2011 13:35:21 GMT</lastBuildDate><ttl>30</ttl><item><title>Bernstein Liebhard LLP Applauds FDA’s Safety Communication on Transvaginal Mesh</title><link>http://www.prweb.com/releases/Bernstein_Liebhard/Transvaginal_Mesh_FDA/prweb8644999.htm</link><pubDate>Fri, 15 Jul 2011 17:35:00 GMT</pubDate><description> <![CDATA[  <p>Bernstein Liebhard LLP is pleased to report that on July 13, 2011, the U.S. Food and Drug Administration issued a public notice, warning health care providers to consider alternative options to transvaginal mesh when treating Pelvic Organ Prolapse because of life-threatening risks associated with the surgical implant.</p><p>(PRWeb July 15, 2011)</p><p>Read the full story at <a href="http://www.prweb.com/releases/Bernstein_Liebhard/Transvaginal_Mesh_FDA/prweb8644999.htm">http://www.prweb.com/releases/Bernstein_Liebhard/Transvaginal_Mesh_FDA/prweb8644999.htm</a></p>]]></description><guid isPermaLink="true">http://www.prweb.com/releases/Bernstein_Liebhard/Transvaginal_Mesh_FDA/prweb8644999.htm</guid></item></channel></rss>